Current role
General Counsel
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Damora Therapeutics, Inc. (DMRA)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Damora Therapeutics, Inc. (DMRA) | — | $400,400 | $854,755 |
| 2024 | Damora Therapeutics, Inc. (DMRA) | — | $400,400 | $897,368 |
| 2023 | Damora Therapeutics, Inc. (DMRA) | — | $385,000 | $554,388 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.